Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer

Fig. 4

Prognosis of patients according to chemotherapy usage at 55 years of age. Rates of Invasive disease-free survival according to chemotherapy usage in (a) patients ≤55 years with RS ≤25, (b) patients ≤55 years with RS > 25, (c) patients > 55 years with RS ≤36, and (d) patients > 55 years with RS > 36

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us